AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus
Go back to AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus| AngioDynamics, Inc. (NASDAQ: ANGO) | Delayed: 15.44 +0.07 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.37 | 52 Week High | $17.64 | |||
| Open | $15.22 | 52 Week Low | $9.71 | |||
| Day High | $15.56 | P/E | N/A | |||
| Day Low | $14.97 | EPS | $-0.07 | |||
| Volume | 997,517 | |||||
